These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29387176)

  • 21. GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential.
    Hamilton JA
    Expert Rev Clin Immunol; 2015 Apr; 11(4):457-65. PubMed ID: 25748625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of Mavrilimumab in Viral Infections Including SARS-CoV-2 Infection - A Brief Review.
    Bhatt K; Garimella R; Taugir R; Mehta I; Jamal M; Vijayan R; Offor R; Nwankwo K; Arif U; Waheed K; Kumari P; Lathiya M; Michel G; Pandya N; Halpern J; Nasir H; Sanchez-Gonzalez MA
    Infect Chemother; 2021 Mar; 53(1):1-12. PubMed ID: 34409778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
    Cid MC; Unizony SH; Blockmans D; Brouwer E; Dagna L; Dasgupta B; Hellmich B; Molloy E; Salvarani C; Trapnell BC; Warrington KJ; Wicks I; Samant M; Zhou T; Pupim L; Paolini JF;
    Ann Rheum Dis; 2022 May; 81(5):653-661. PubMed ID: 35264321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial.
    Behrens F; Tak PP; Østergaard M; Stoilov R; Wiland P; Huizinga TW; Berenfus VY; Vladeva S; Rech J; Rubbert-Roth A; Korkosz M; Rekalov D; Zupanets IA; Ejbjerg BJ; Geiseler J; Fresenius J; Korolkiewicz RP; Schottelius AJ; Burkhardt H
    Ann Rheum Dis; 2015 Jun; 74(6):1058-64. PubMed ID: 24534756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the efficacy and safety of tofacitinib and mavrilimumab in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials.
    Sung YK; Lee YH
    Int J Clin Pharmacol Ther; 2021 Aug; 59(8):557-565. PubMed ID: 33860755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model.
    Plater-Zyberk C; Joosten LA; Helsen MM; Koenders MI; Baeuerle PA; van den Berg WB
    Ann Rheum Dis; 2009 May; 68(5):721-8. PubMed ID: 18495731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Efficacy of Mavrilimumab For Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    Shamseldin LS; Shawqi MM; Al Hashem NA; Alhyari MAH; Abd Elazeem HAS; Elghazaly SM; Hamdallah A; Ragab KM; Nourelden AZ
    Curr Rheumatol Rev; 2021; 17(2):184-192. PubMed ID: 33185165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study.
    De Luca G; Cavalli G; Campochiaro C; Della-Torre E; Angelillo P; Tomelleri A; Boffini N; Tentori S; Mette F; Farina N; Rovere-Querini P; Ruggeri A; D'Aliberti T; Scarpellini P; Landoni G; De Cobelli F; Paolini JF; Zangrillo A; Tresoldi M; Trapnell BC; Ciceri F; Dagna L
    Lancet Rheumatol; 2020 Aug; 2(8):e465-e473. PubMed ID: 32835256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping of human granulocyte-macrophage-colony-stimulating-factor domains interacting with the human granulocyte-macrophage-colony-stimulating-factor-receptor alpha-subunit.
    Brown CB; Pihl CE; Kaushansky K
    Eur J Biochem; 1994 Nov; 225(3):873-80. PubMed ID: 7957224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial.
    Cremer PC; Abbate A; Hudock K; McWilliams C; Mehta J; Chang SY; Sheng CC; Van Tassell B; Bonaventura A; Vecchié A; Carey B; Wang Q; Wolski KE; Rajendram P; Duggal A; Wang TS; Paolini JF; Trapnell BC;
    Lancet Rheumatol; 2021 Jun; 3(6):e410-e418. PubMed ID: 33754144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis.
    Greven DE; Cohen ES; Gerlag DM; Campbell J; Woods J; Davis N; van Nieuwenhuijze A; Lewis A; Heasmen S; McCourt M; Corkill D; Dodd A; Elvin J; Statache G; Wicks IP; Anderson IK; Nash A; Sleeman MA; Tak PP
    Ann Rheum Dis; 2015 Oct; 74(10):1924-30. PubMed ID: 24936585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.
    Cook AD; Braine EL; Campbell IK; Rich MJ; Hamilton JA
    Arthritis Res; 2001; 3(5):293-8. PubMed ID: 11549370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.
    Haworth C; Brennan FM; Chantry D; Turner M; Maini RN; Feldmann M
    Eur J Immunol; 1991 Oct; 21(10):2575-9. PubMed ID: 1915559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model-Based Discovery and Development of Biopharmaceuticals: A Case Study of Mavrilimumab.
    Wang B; Wu CY; Jin D; Vicini P; Roskos L
    CPT Pharmacometrics Syst Pharmacol; 2018 Jan; 7(1):5-15. PubMed ID: 28836356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha.
    Alvaro-Gracia JM; Zvaifler NJ; Brown CB; Kaushansky K; Firestein GS
    J Immunol; 1991 May; 146(10):3365-71. PubMed ID: 2026869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis.
    Fuentelsaz-Romero S; Cuervo A; Estrada-Capetillo L; Celis R; García-Campos R; Ramírez J; Sastre S; Samaniego R; Puig-Kröger A; Cañete JD
    Front Immunol; 2020; 11():613975. PubMed ID: 33679701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis.
    Huizinga TW; Batalov A; Stoilov R; Lloyd E; Wagner T; Saurigny D; Souberbielle B; Esfandiari E
    Arthritis Res Ther; 2017 Mar; 19(1):53. PubMed ID: 28274253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: a possible role in rheumatoid arthritis.
    Alvaro-Gracia JM; Zvaifler NJ; Firestein GS
    J Exp Med; 1989 Sep; 170(3):865-75. PubMed ID: 2504878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI of the joint and evaluation of the granulocyte-macrophage colony-stimulating factor-CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study.
    Genovese MC; Berkowitz M; Conaghan PG; Peterfy C; Davy K; Fisheleva E; Gupta A; Inman D; Janiczek R; Layton M; Mitchell N; Patel J; Roberts A; Saurigny D; Smith JE; Williamson R; Tak PP
    Lancet Rheumatol; 2020 Nov; 2(11):e666-e676. PubMed ID: 38279363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions.
    Xu WD; Firestein GS; Taetle R; Kaushansky K; Zvaifler NJ
    J Clin Invest; 1989 Mar; 83(3):876-82. PubMed ID: 2646320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.